Top News
BioNTech/Pfizer expect new variant impact data ‘within 2 weeks’
Germany's BioNTech said Friday it was urgently studying how well the coronavirus vaccine it developed with Pfizer protects against the new B.1.1.529 variant detected in South Africa.
Follow Us on Google News





























